Oragenics Inc (OGEN)

US · Healthcare · Biotechnology

$0.55+3.91%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-2.2M

Profit YoY

+0.7%

EPS

$-0.51

Market cap

$2.4M

Forward P/E

0.0

P/B

0.36

Book value

$1.41

EPS (TTM)

$-1.42

52-week high

$1.45

52-week low

$0.48

50-day MA

$0.57

200-day MA

$0.78

Beta

1.24

Analysts rate Oragenics Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $2.00.

Insiders

1.93%

Institutions

6.28%

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Oragenics Inc — free to start.

Data updated 2026-08-05.